IDT Australia (IDT) - Sterile Manufacturing Licence Opens Sales Opportunities
Last month the Therapeutic Goods Administration (TGA) upgraded IDT’s sterile manufacturing licence, allowing it to manufacture and release...
375 Views
IDT Australia (IDT) - Antibody Drug Conjugates Seen as the Path to Growth
We like the focus on ADC drugs, which is playing to IDT’s strength in high containment manufacture of cytotoxic drugs. IDT has applied to the TGA...
371 Views
IDT Australia (IDT) - RNA Opportunity Squeezed by BioNTech & CSL
The opportunity for IDT to establish itself as a significant player in mRNA drug manufacture in Australia has diminished in recent months.
323 Views
IDT Australia (IDT): Poised to Benefit from RNA and On-Shoring
DT Australia has a long track record as a manufacturer of pharmaceutical drugs, including both active pharmaceutical ingredients (API) and finished...
369 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
5.8k Views
No more insights